Hainan Shuangcheng produces drug stability test chambers, drug storage chambers, drug low-temperature test chambers, constant temperature and humidity rooms, and other equipment that are widely used in Hainan Shuangcheng

Hainan Shuangcheng Pharmaceutical Co., Ltd. is a high-tech enterprise established in 2000, specializing in the research and development, production, and sales of chemically synthesized peptide drugs. The company was listed on the Shenzhen Stock Exchange's SME board on August 8, 2012,Abbreviated as "Shuangcheng Pharmaceutical", code "002693".

The company has rich experience in the research and development, registration, production, and marketing of chemically synthesized peptide drugs. In the Chinese market, it has successfully developed three chemically synthesized peptide drugs, namely Jitai (injection thymus method), injection somatostatin, and injection thymopentin. Multiple chemically synthesized peptide drugs are currently being registered and applied for. The company has a chemical synthetic peptide API production workshop certified by the US FDA; Freeze drying workshop certified by EU GMP. We have rich experience in production management of freeze-dried powder injection formulations for injection, with four freeze-dried formulation workshops that meet Chinese GMP requirements and an annual production capacity of nearly 80 million units.

The company has passed GMP inspections by the European Union and the US FDA, and has a chemical synthetic peptide raw material production workshop certified by the US FDA; The company's main product, thymus injection method, has recently passed EU certification.
Since its establishment, Shuangcheng Pharmaceutical has developed rapidly, with a marketing network covering more than 30 provinces, municipalities and autonomous regions in mainland China. It has cooperated with over 600 pharmaceutical merchants and its products have covered more than 10000 hospital terminals. Has a stable sales position in the same industry.
The company adheres to the corporate philosophy of "the beauty of becoming a person, the desire to become oneself". The beauty of becoming a person is conveyed through sincerity, and the desire to become oneself is forged through hard work. While achieving the development of the enterprise itself, the company actively fulfills its corporate social responsibility and gives back to society. The company has been rated as a tax credit rating * enterprise by the Hainan Provincial State Taxation Bureau and the Hainan Provincial Local Taxation Bureau multiple times.
In the future, the company's development strategy is to become a major supplier of global peptide raw materials and a major producer of global peptide generic drug formulations.